Engineered Bacteria Increase L-Arginine to Improve Immunotherapy Response

Skip Nav Destination

Article navigation

Research Watch| December 02 2021

Online Issn: 2159-8290

Print Issn: 2159-8274

2021

American Association for Cancer Research.

Cancer Discov (2021) 11 (12): 2956.

Abstract

Engineered bacteria increase intratumoral L-arginine which synergizes with immune checkpoint therapies.

2021

American Association for Cancer Research.

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.